Skip to content
Screener

Eli Lilly LLY Total Revenue

Total Revenue at other companies

Pfizer logo
PfizerPFE
$15.03B+2.6%
Amgen logo
AmgenAMGN
$10.05B+9.5%
Cardinal Health, Inc. logo
Cardinal Health, Inc.CAH
$63.67B+5.8%
Mannkind logo
MannkindMNKD
$109.37M+42.9%
McKesson logo
McKessonMCK
$105.38B+7.7%
Exelixis logo
ExelixisEXEL
$628.69M+10.6%

Segments

By product

See full
Mounjaro$9.94B+91.2%
Zepbound$4.93B+45.8%
Verzenio$1.47B-1.0%
Jardiance$1.23B+78.6%
Trulicity$1.22B+11.6%
Other oncology$1.1B+18.6%

By geography

See full
U.S.$5.18B
Japan$534.8M
China$376.4M

By segment

See full
Reportable Segment$22.97B+47.7%

Other financials

Income statement

See full
Gross profit$19.7B+50.3%
Net income$7.1B+25.3%
EPS (diluted)$7.94+26.2%

Balance sheet

See full
Cash & equivalents$9.0B+165%
Total debt$54.9B+37.6%
Total equity$33.9B+85.4%
Total assets$142.28B+41.0%

Cash flow

See full
Operating cash flow$10.7B+246%
CapEx$2.9B+72.8%
Free cash flow$7.8B+458%

Valuation

See full
Market cap$1.06T+61.1%
Enterprise value$1.11T+59.2%
P/E39.7×-8.0×
P/S13.3×+1.0×

Profitability

See full
Gross margin83.4%+0.8pp
Net margin33.5%+7.6pp
FCF margin22.8%+13.7pp

Returns & leverage

See full
Return on equity102.4%+15.7pp
Debt / equity1.6×-0.6×
Current ratio1.4×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Eli Lilly’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:40 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000059478-26-000081
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue$22,974$15,558$42,773$28,286
Costs, expenses, and other:
Cost of sales3,2682,4486,8454,672
Research and development3,8193,3367,3296,070
Marketing, selling, and administrative3,4302,7536,3645,221
Acquired in-process research and development2,7761543,3601,726
Asset impairment, restructuring, and other special charges70398235
Other–net, (income) expense(269)90(204)329

Item 1. Financial Statements

FAQ

What is Eli Lilly's total revenue?
Eli Lilly (LLY) reported total revenue of $22.97B in Q2 2026.
How has Eli Lilly's total revenue changed year-over-year?
Eli Lilly's total revenue increased by 47.7% year-over-year, from $15.56B to $22.97B.
What is the long-term trend for Eli Lilly's total revenue?
Over 4 years (2021 to 2025), Eli Lilly's total revenue has grown at a 23.2% compound annual growth rate (CAGR), from $28.32B to $65.18B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Eli Lilly's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude